EICHOR
● Completed
Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia
Condition: Presbyopia · Refractive Error · Eye Diseases · Sponsor: LENZ Therapeutics, Inc
About this study
Phase 3 study to evaluate the safety and effectiveness of LNZ100 \& LNZ101 for the treatment of Presbyopia.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (25)
| Site #106 | Chandler, Arizona, United States | — |
| Site #121 | Mesa, Arizona, United States | — |
| Site #122 | Phoenix, Arizona, United States | — |
| Site #124 | Phoenix, Arizona, United States | — |
| Site #128 | Scottsdale, Arizona, United States | — |
| Site #125 | Sun City, Arizona, United States | — |
| Site #130 | Azusa, California, United States | — |
| Site #110 | Garden Grove, California, United States | — |
| Site #101 | Glendale, California, United States | — |
| Site #129 | Newport Beach, California, United States | — |
| Site #107 | Petaluma, California, United States | — |
| Site #126 | Rancho Cordova, California, United States | — |
+ 13 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.